Galectin Therapeutics (GALT) Intangibles (2010 - 2016)
Galectin Therapeutics' quarterly Intangibles came in at $78000.0 in Q4 2016, up 875.0% year-on-year from $8000.0 in Q1 2016, and up 2500.0% quarter-over-quarter from $3000.0 in Q3 2016.
Galectin Therapeutics has reported Intangibles for 7 years, with the latest figure at $78000.0 in Q4 2016.
- For the quarter ending Q4 2016, Intangibles rose 875.0% year-over-year to $78000.0; the trailing twelve-month figure through Dec 2016 stood at $78000.0 (up 875.0% YoY), and the FY2016 full-year result was $78000.0, up 875.0% from the prior year.
- Intangibles for Q4 2016 stood at $78000.0, up from $3000.0 in the prior quarter.
- The five-year high for Intangibles was $78000.0 in Q4 2012, with the low at $3000.0 in Q3 2016.
- Average Intangibles over 5 years is $27250.0, with a median of $20000.0 recorded in 2014.
- Year-over-year, Intangibles tumbled 80.77% in 2014 and jumped 875.0% in 2016.
- Tracing GALT's Intangibles over 5 years: stood at $78000.0 in 2012, then changed by 0.0% to $78000.0 in 2013, then plunged by 80.77% to $15000.0 in 2014, then tumbled by 46.67% to $8000.0 in 2015, then jumped by 875.0% to $78000.0 in 2016.
- The last three Intangibles figures came in at $78000.0 (Q4 2016), $3000.0 (Q3 2016), and $5000.0 (Q2 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 4.41 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 11,640.44 |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 418.50 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.29 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 78,000.00 |
| Sep 30, 2016 | 3,000.00 |
| Jun 30, 2016 | 5,000.00 |
| Mar 31, 2016 | 7,000.00 |
| Dec 31, 2015 | 78,000.00 |
| Sep 30, 2015 | 10,000.00 |
| Jun 30, 2015 | 12,000.00 |
| Mar 31, 2015 | 14,000.00 |
| Dec 31, 2014 | 15,000.00 |
| Sep 30, 2014 | 17,000.00 |
| Jun 30, 2014 | 19,000.00 |
| Mar 31, 2014 | 21,000.00 |
| Dec 31, 2013 | 23,000.00 |
| Sep 30, 2013 | 24,000.00 |
| Jun 30, 2013 | 26,000.00 |
| Mar 31, 2013 | 28,000.00 |
| Dec 31, 2012 | 30,000.00 |
| Sep 30, 2012 | 33,000.00 |
| Jun 30, 2012 | 34,000.00 |
| Mar 31, 2012 | 35,000.00 |
| Dec 31, 2011 | 36,000.00 |
| Sep 30, 2011 | 37,000.00 |
| Jun 30, 2011 | 38,000.00 |
| Dec 31, 2010 | 39,000.00 |